Syndax Pharmaceuticals (SNDX) Net Margin (2015 - 2026)
Syndax Pharmaceuticals (SNDX) reported Net Margin of -67.82% for Q2 2026, up 121.46 percentage points from -189.28% a year earlier but down 2.03 percentage points from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Net Margin (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Syndax Pharmaceuticals' Net Margin came in at -87.52%, up 340.96 percentage points year-over-year; for FY2025, it came in at -165.60%, up 1180.50 percentage points from FY2024.
- Net Margin has a five-year change of +4656.94 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at -1346.11% in FY2024 and 17.84% in FY2021 (+4840.39 pp).
- Five-year quarterly Net Margin spans a low of -1944.66% in Q2 2024 and a high of 76.00% in Q4 2021.
- Year over year, Net Margin has now increased in each of the last five quarters, with an average year-over-year change of +780.45 percentage points over the last five quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at -65.79% (Q1 2026), -98.96% (Q4 2025) and -132.36% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Syndax Pharmaceuticals | 1.59 Bn | -137.74 Mn | 69.58 Mn | -67.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -67.82% |
| Mar 31, 2026 | -65.79% |
| Dec 31, 2025 | -98.96% |
| Sep 30, 2025 | -132.36% |
| Jun 30, 2025 | -189.28% |
| Mar 31, 2025 | -423.34% |
| Dec 31, 2024 | -1,226.16% |
| Sep 30, 2024 | -673.01% |
| Jun 30, 2024 | -1,944.66% |
| Dec 31, 2021 | 76.00% |
| Sep 30, 2021 | -166.78% |
| Jun 30, 2021 | -6,044.85% |
| Mar 31, 2021 | -7,314.78% |
| Dec 31, 2020 | -5,374.47% |
| Sep 30, 2020 | -5,392.35% |
| Jun 30, 2020 | -4,501.85% |
| Mar 31, 2020 | -4,020.05% |
| Dec 31, 2019 | -3,684.21% |
| Sep 30, 2019 | -3,384.96% |
| Jun 30, 2019 | -3,935.62% |
API Access
Syndax Pharmaceuticals Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();